Randomised Single Dose 3 Way Crossover Single Blind Study to Evaluate the Pharmacokinetic Dose Proportionality, Compare the Bioavailability and Safety of Clonidine Mucoadhesive Buccal Tablets (MBT) With Catapres in Normal Healthy Volunteers

Trial Profile

Randomised Single Dose 3 Way Crossover Single Blind Study to Evaluate the Pharmacokinetic Dose Proportionality, Compare the Bioavailability and Safety of Clonidine Mucoadhesive Buccal Tablets (MBT) With Catapres in Normal Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 19 Jul 2017

At a glance

  • Drugs Clonidine (Primary) ; Clonidine
  • Indications Stomatitis
  • Focus Pharmacokinetics
  • Sponsors Onxeo SA
  • Most Recent Events

    • 19 Jul 2017 Results published in the Advances in Therapy
    • 11 Oct 2016 Results of this study, presented at the 41st European Society for Medical Oncology Congress.
    • 15 Apr 2016 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top